Guest guest Posted April 20, 2002 Report Share Posted April 20, 2002 Mayo Clinic Study Mayo Clinic Rochester Thursday, September 09, 1999 Mayo Clinic Study Implicates Fungus as Cause of Chronic Sinusitis ROCHESTER, MINN. -- Mayo Clinic researchers say they have found the cause of most chronic sinus infections -- an immune system response to fungus. They say this discovery opens the door to the first effective treatment for this problem, the most common chronic disease in the United States. (See graph.) An estimated 37 million people in the United States suffer from chronic sinusitis, an inflammation of the membranes of the nose and sinus cavity. Its incidence has been increasing steadily over the last decade. Common symptoms are runny nose, nasal congestion, loss of smell and headaches. Frequently the chronic inflammation leads to polyps, small growths in the nasal passages which hinder breathing. " Up to now, the cause of chronic sinusitis has not been known, " say the Mayo researchers: Drs. Sherris, Eugene Kern and Jens Ponikau , Mayo Clinic ear, nose and throat specialists. Their report appears in the September issue of the journal Mayo Clinic Proceedings. " Fungus allergy was thought to be involved in less than ten percent of cases, " says Dr. Sherris. " Our studies indicate that, in fact, fungus is likely the cause of nearly all of these problems. And it is not an allergic reaction, but an immune reaction. " The researchers studied 210 patients with chronic sinusitis. Using new methods of collecting and testing mucus from the nose, they discovered fungus in 96 percent of the patients' mucus. They identified a total of 40 different kinds of fungi in these patients, with an average of 2.7 kinds per patient. In a subset of 101 patients who had surgery to remove nasal polyps, the researchers found eosinophils (a type of white blood cell activated by the body's immune system) in the nasal tissue and mucus of 96 percent of the patients. The results, the researchers say, clearly portray a disease process in which, in sensitive individuals, the body's immune system sends eosinophils to attack fungi and the eosinophils irritate the membranes in the nose. As long as fungi remain, so will the irritation. " This a potential breakthrough that offers great hope for the millions of people who suffer from this problem, " says Dr. Kern. " We can now begin to treat the cause of the problem instead of the symptoms. " More research is underway at Mayo Clinic to confirm that the immune response to the fungus is the cause of the sinus inflammation. The researchers are also working with pharmaceutical companies to set up trials to test medications to control the fungus. They estimate that it will be at least two years before a treatment will be widely available. The researchers distinguish chronic sinusitis -- sinusitis that lasts three months or longer -- from acute sinusitis, which lasts a month or less. They say that the cause of the acute condition is usually a bacterial infection. Antibiotics and over-the-counter decongestants are widely used to treat chronic sinusitis. In most cases, antibiotics are not effective for chronic sinusitis because they target bacteria, not fungi. The over-the-counter drugs may offer some relief of symptoms, but they have no effect on the inflammation. " Medications haven't worked for chronic sinusitis because we didn't know what the cause of the problem was, " says Dr. Ponikau. " Finally we are on the trail of a treatment that may actually work. " Thousands of kinds of single-cell fungi (molds and yeasts) are found everywhere in the world. Fungal spores (the reproductive part of the organism) become airborne like pollen. Some people develop allergies to fungi. The new evidence from the Mayo study suggests that many people also develop a different kind of immune system response. Contact: e-mail: newsbureau@... Also see Statement for Patients Full-text report from Mayo Clinic Proceedings LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE USE OF THIS SITE SIGNIFIES YOUR AGREEMENT TO THE TERMS OF USE File news_773.html last modified: Tuesday, 19-Mar-2002 14:57:08 CST Copyright © 1996-2002 Mayo Foundation for Medical Education and Research. > > Hello All, > > Can anyone direct me to some certain information without me having to spend hours searching for it? I am in need of this for the media binder that I'm preparing for next week. If you can be of assistance, please write me directly at this addy. You might also post to the group too as it might help others as well. Below is what I need: > > 1. Where to find the Mayo Clinic study on Rhinosinusitis and Mold exposure; > > 2. The Long Article that was posted on either this group or toxic mold survivors group: It was on how long scientists, etc. have known about mold exposures and health concerns. It believe it was posted by a doctor. I can't remember which group... it could be been TMS. (I hope someone remembers this article as it was a great one.) > > 3. Any information regarding the CA Toxic Mold Bill; and any other states that have bills of this nature; > > 4. The Mark Tatum Story by the Associated Press with the picture without his prosthetic face. Mark has mucormycosis. > > 5. The JAMA article pertaining to mycotoxins that came out a while back. Can this be obtained without cost? > > 6. And if there is any way to quickly find a number of articles on SCHOOLS WITH TOXIC MOLD; > > 7. and lastly (I think): Any information pertaining to Toxic Mold and Multiple Chemical Sensitivity. The article by Sheila Bastein was good, but don't know where to obtain a copy from the internet. > > YOUR HELP IS GREATLY APPRECIATED. Also, thanks to all that have been so gracious to send personal stories for the binder that I'm preparing. I will be forever grateful! > > Beverly Weikert > > National Toxic Mold Coalition > > Public Relations Supervisor/Board Member > > www.geocities.com/marbme12/NTMC.html > > Homeowners Against Deficient Dwellings > > Indiana Representative > > www.hadd.com > > Consultant to The Environmental Health Research Group > > www.myhealthrights.com > > > > > > --------------------------------- > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 20, 2002 Report Share Posted April 20, 2002 More on Mayo Clinic Type in Dr. Sherris on the Mayo Search, he is one of the Dr's that did the research Allergic Diseases Division Department of Internal Medicine Home Specialty Clinics How to Make an Appointment Patient Information Referring Physician Outreach Medical Staff Education Research Clinical Research Program List of Medical Specialties Patient Amenities Maps of Mayo Campus Traveling to Rochester Lodging in Rochester Community Information Checklist Rochester Weather Other Allergic Diseases The Division of Allergic Diseases provides a wide range of services for the evaluation, diagnosis and treatment of many other allergic and respiratory diseases other than those listed in the specialty clinics on our web site. The following is a listed (although not all inclusive) are other diseases that are evaluated. Allergic bronchopulmonary aspergillosis Anaphylaxis Churg Strauss Vasculitis Allergic Conjunctivitis Cough Drug allergy Farmers Lung Flushing Syndromes Hypersensitivity pneumonitis Mastocytosis Nasal drainage, infections, polyps Occupational asthma Sarcoidosis The physician at the Mayo Clinic, that is an Allergy/Asthma specialist, performs a comprehensive history and physical examination. This will include reviewing of outside information provided by the patient. To make an appointment and get general informations please call our appointment secretary at 507-284-9989. Investigation is individualized and may include allergy skin testing, pulmonary function tests, methacholine bronchial challenge tests, rhinoscopy and upper airway endoscopy. All of this is available within the area of the Allergy Division to maximize convenience, utilization of resources and patient's time; and is under the direct supervision of the allergist. Other testing and consultation that may need to be done will be individualized. Such testing may include allergy blood tests (RAST), measurement of blood counts and total IgE. Chest x-ray and high resolution CT scan of the lungs and sinuses may be required to detect structural abnormalities or disease entities that could be causing or aggravating the patient's breathing problems. If a consultation with other specialists is needed, they are easily obtainable and available in the same building where the Allergy Division is located. Upon completion of testing and consultations the Mayo Clinic Allergy/Asthma specialist will compile the information and offer the diagnosis, treatment plan, answer any questions and arrange follow-up plans. Other Allergic Diseases Interest Group Butterfield, J. H. Frigas, E. Hagan, J. B. Li, J. T. C. Maddox, D. E. Van Dellen, R. G. Volcheck, G. W. Weiler, C. R. How to Make an Appointment Please call the Allergy Appointment Office at 507 284-9989 or fax at 507 284-5771. Our appointment office is open from 8:00 a.m. until 5:00 p.m. Monday-Friday. The Clinic is closed on Saturday and Sunday. Appointments can be made by telephone or by mail. There are no appointments available by e-mail. Mayo Clinic Publications on Other Allergic Diseases Blomgren JA, Markus PJ, Osmon DR, Estes LL, Hanssen AD, Li JTC. Perioperative prophylactic antimicrobial selection in orthopedic patients with a history of penicillin and/or cephalosporin allergy. J Allergy Clin Immunol 107(2):S2, 2001 Li JTC, Markus PJ, Osmon DR, Estes LL, Gosselin VA, Hanssen AD. Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy. J Allergy Clin Immunol 105(1 Pt 2):S339, 2000. Markus PJ, Kloos KE, Li JTC. Prevalence of self-reported allergy in patients admitted for medical or surgical procedures. Ann Allergy Asthma Immunol 86(1):106, 2001. Li JTC, Estes LL, Markus PJ, Osmon DR, Gosselin VA, Hanssen AD. Penicillin and cephalosporin allergy in hospitalized patients. Ann Allergy Asthma Immunol 84:109, 2000. Valyasevi MA; Van Dellen RG. Frequency of systemic reactions to penicillin skin tests. Ann Allergy, Asthma & Immunol. 2000;85:363- 365. Gross MD, Andriacci F, Gordon R, Maddox DE: Sarcoidosis presenting as subcutaneous nodules. Arch Department of Dermatology, 113:1442, 1997. Maddox DE: Occupational allergic disease. Clin Immunol Newsletter 10 (2):23-29, 1990. Frigas E: Testing for bronchial sensitivity to formaldehyde gas. Mayo Clin Proc 56:277, (April) 1981. nsen RK, Butterfield, JH, Kao PC, Frigas E: Alternative medicines for asthma. European J of Allergy and Clin Immunol (Supp.) 51:57, April 1996. (Abstract) Butterfield JH, Schwenk NM, Colville DS, Kuipers BJ: Severe Generalized Reactions to Ibuprofen: Report of a Case. J Rheumatol, 649-650, 1986. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Autonomously Growing Human Mast Cell Leukemia Line. Fed Proc, 45:736, 1986. Leiferman KM, Haugen HS, Gleich GJ, Butterfield JH: Subpopulations of Human Skin Mast Cells Containing Major Basic Protein: Association with Diseases Involving Mast Cells. J Invest Dermatol, 88:503, April, 1987. Weiler D, Haugen HS, Leiferman KM, Gleich GJ, Butterfield JH: Mast Cells in Carnoy's Fixed Tissue Stain Positively for Eosinophil Major Basic Protein (MBP). Fed Proc, 46:936, 1987. Leiferman KM, Weiler DA, Haugen HS, Gleich GJ, Butterfield JH: Endocytosis of Eosinophil Granule Major Basic Protein by Mast Cells. J Invest Dermatol, 90:581, April, 1988. Butterfield JH, Weiler DA, Roche PC: Purification of Tryptase from a Human Mast Cell Line. J Allergy Clin Immunol, 83:217 January, 1989. Weiler DA, Butterfield JH: In Vitro Sensitivity of Human Mast Cells to Chemotherapeutic Agents. J Allergy Clin Immunol, 83:234, January, 1989. Hunt LW, Weiler DA, Colby TV, Gleich GJ, Butterfield JH: Quantitation of Mast Cells in Usual Interstitial Pneumonitis (UIP) Using an Indirect Immunofluorescent Stain for Mast Cell Tryptase. Chest, 92:171, August, 1989. Bubak ME, Wentz-Murtha PE, Dunnette SL, Keating MU, Wallen ND, Weiler DA, Butterfield JH, Blomgren JA, Pfenning MA, Gleich GJ, CE: Eosinophil Derived Neurotoxin (EDN) in Nasal Lavages Correlates With Weekly Hay Fever Symptoms During Seasonal Exposure While Mast Cell Tryptase Does Not. Ann Allergy, 66:66, 1991. Hunt LW, Geich GJ, Butterfield JH: Mast Cells in Fatal Asthma: Visualization with an Immunofluorescent Stain to Mast Cell Tryptase. Am Rev of Respir Dis, 142:A41, April, 1991. Finoto S, Marshall J, Irani A, Schwartz L, Butterfield JH, Ohno I, Dolovich J, Jordana M, Denburg J: Regulation of Protease and Cytokine Expression in a Human Mast Cell Line (HMC-1): Effect of Nasal Polyp Structural Cell-Derived Conditioned Media. J Allergy Clin Immunol, 89:246, January, 1992. Van Oosterhout AJM, Butterfield JH, Delsman KC, Nijkamp FP: Human Mast Cell Lines HMC-1 and D5 Subclone Produce Lipid Mediators But Do Not Actively Release Histamine. Am Rev of Respir Dis, 145:A-852, May, 1992. Buckely M, J, J, Ray K, Butterfield JH: Production of Cytokines in a Human Mast Cell Line. " Cells and Cytokines in Lung Inflammation " . Paris, France, 24-25, June, 1993 Butterfield JH, Khan DA: Measurement of a Prostaglandin D2 (PGD2) Metabolite in Urine of Patients with Systemic Mast Cell Disease (SMD). J Allergy Clin Immunol, 93:383, January, 1994. Yocum MW, Butterfield JH, Gharib H: Elevated Serum Calcitonin Levels in Systemic Mast Cell Disease. Poster presented at American Associates of Clinical Endocrinologists. New Orleans, April, 1994. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundstrom C, Nilsson K, Hellman L: Phenotypic Characterization of the Human Mast-Cell Line HMC-1. Scand J Immunol, 39:489-498, 1994. Tam SY, Tsai M, Butterfield JH, Galli SJ: Expression of Functional TRK a Receptor Tyrosine Kinase in Human Mast Cell Line HMC-1. Society for Neuroscience Abstracts, Vol. 20, 1994. Talley NJ, Butterfield JH, E: Mast Cell Infiltration and Degranulation in Colonic Mucosa in Irritable Bowel Syndrome. Gastroenterology, 105:A697, 1995. Chan H, Tanaka R, JM, Butterfield JH: Tryptase cDNA Sequences in a Human Mast Cell Line. Faseb J, 9:A1343. Butterfield JH, Kao PC, Klee GG, Yocum MW: Aspirin Idiosyncrasy in Systemic Mast Cell Disease: Positive Cytochemical Staining of HMC-1 cells for Calcitonin and Calcitonin Gene-Related Peptide. Poster presented at American College of Allergy, Asthma, & Immunology. Dallas, TX, November, 1995. Baghestanian M, Agis H, Bevec D, Bankl HC, Butterfield JH, Füreder W, Willheim M, Müller MR, Lechner K, Valent P: SCF-Mediated Downregulation of c-kit in Human Mast Cells. J Invest Dermat, 105 (5):717, 1995. Love KS, Lakshmanan RR, Butterfield JH, Fox CC: Expression of MHC Class II Molecules on HMC-1 Cells is Upregulated by IFN-? but not IL- 4. J Allergy Clin Immunol, 97:313, January, 1996. Jaffe JS, Wang Y, Post TJ, Glaum MC, Raible DG, Mohanty JG, Butterfield JH, Lang DM, Schulman ES: Activated Human Lung Fragments and Human Mast Cells Synthesize IL-13. J Allergy Clin Immunol, 97:707, January 1996. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an Immature Mast Cell Line from a Patient with Mast Cell Leukemia. Leuk Res, 12:345-355, 1988. Butterfield JH, Marcoux JP, Weiler D, Harner SG: Mast Cell Pharyngitis As a Cause of Supraglottic Edema. Archives of Otorhinolaryngol, 245:88-91, 1988. Butterfield JH, Weiler DA: In Vitro Sensitivity of Immature Human Mast Cells to Chemotherapeutic Agents. Int Arch Allergy Appl Immunol, 89:297-300, 1989. Butterfield JH, Weiler DA, Hunt LW, Wynn SR, Roche PC: Purification of Tryptase From a Human Mast Cell Line. J Leuk Biol, 47:409-419, 1990. Valent P, Besemer J, Sillaber, Butterfield JH, Eher R, Majdic O, Kishi K, Klepetko W, Eckersberger F, Lechner K, Bettelheim P: Failure to Detect IL-3 Binding Sites on Human Mast Cells. J Immunol, 145:3432- 3437, 1990. Valent P, Bevec D, Maurer D, Besemer J, De Padova F, Butterfield JH, Speiser W, Majdic O, Lechner K, Bettelheim P: Interleukin 4 Promotes Expression of Mast Cell ICAM-1 Antigen. Proc Natl Acad Sci USA, 88:3339-3342, 1991. Sillaber C, Strobl H, Bevec LD, Ashman L, Butterfield JH, Lechner K, Maurer D, Bettelheim P, Valent P: IL-4 Regulates C-kit Proto-Oncogene Product Expression in Human Mast and Myeloid Progenitor Cells. J Immunol, 147:4224-4228, 1991. Hunt LW, Colby TV, Weiler DA, Sur S, and Butterfield JH: Immunofluorescent Staining for Mast Cells in Idiopathic Pulmonary Fibrosis: Quantification and Evidence for Extracellular Release of Mast Cell Tryptase. Mayo Clin Proc, 67:941-948, 1992 Gauchat JF, Henchoz S, Mazzel G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, -Romo L, J, Kishi K, Butterfield JH, Dahinden C, Bonnefoy JY: Induction of Human IgE Synthesis in B Cells by Mast Cells and Basophils. Nature, 365:340-343, September, 1993. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y: Identification of Mutations in the Coding Sequence of the Proto-Oncogene C-Kit in a Human Mast Cell Leukemia Cell Line Causing Ligand-Independent Activation of C-Kit Product. J Clin Invest, 92:1736-1744, October, 1993. Buckley MG, CMM, J, Pryor P, Ray K, Butterfield JH, JW: IL-4 Enhances IL-3 and IL-8 Gene Expression in a Human Leukemic Mast Cell Line. J Immunol, 84:410-415, 1995. Butterfield JH, Kao PC, Klee GG, Yocum, MW: Aspirin Idiosyncrasy in Systemic Mast Cell Disease: A New Look at Mediator Release During Aspirin Desensitization. Mayo Clin Proc, 70:481-487, 1995. Molinari JF, WR, J, Tanaka R, Butterfield JH, Abraham WM: Role of Tryptase in Immediate Cutaneous Responses in Allergic Sheep. J Appl Physiol, 79(6):1966-1970, 1995. Love KS, Lakshmanan RR, Butterfield JH, Fox CC: IFN-? Stimulated Enhancement of MHC Class II Antigen Expression by the Human Mast Cell Line HMC-1. Cellular Immunol, 170:85-90, 1996. Agis H, Fureder W, Bankl HC, Kundi M, Sperr WR, Willheim M, Boltz- Nitulescu G, Butterfield JH, Kishi K, Lechner K, Valent P: Comparative Immunophenotypic Analysis of Human Mast Cells, Blood Basophils and Monocytes. Immunol, 87:535-543, 1996. Werfel T, Oppermann M, Butterfield JH, Begemann G, Elsner J, Gotze O, Zwirner J: The Human Mast Cell Line HMC-1 Expresses C5a Receptors and Responds to C5a but not to C5a(desArg). Scand J Immunol, 44:30-36, 1996. Wedi B, Elsner J, Czech W, Butterfield JH, Kapp A: Modulation of Intercellular Adhesion Molecule 1 (ICAM-1) Expression on the Human Mast Cell Line (HMC)-1 by Inflammatory Mediators. Allergy, 51:676- 684, 1996. Baghestanian M, Agis H, Bevec D, Bankl HC, Hofbauer R, Kress HG, Butterfield JH, Müller MR, Ashman LK, Füreder W, Willheim M, Lachner K, Valent P: Stem Cell Factor-Induced Downregulation of c-kit in Human Lung Mast Cells and HMC-1 Mast Cells. Exp Hemat, 24:1377-1386, 1996. Jaffe JS, Raible DG, Post TJ, Wang Y, Glaum MC, Butterfield JH, Schulman ES: Human Lung Mast Cell Activation Leads to IL-13 mRNA Expression and Protein Release. Am J Respir Cell Mol Biol, 15:473- 481, 1996. Finotto S, Marshall JS, Butterfield JH, Denburg JA: Specific Inhibition of ?-Tryptase Expression in a Human Mast Cell Line by Granulocyte-Macrophage Colony-Stimulating Factor Produced by Airways Structural Cells. Am J Respir Cell Mol Biol, 15:355-360, 1996. Wedi B, Lewrick H, Butterfield JH, Kapp A: Human HMC-1 Mast Cells Exclusively Express the Fc?RII Subtype of IgG Receptor. Arch Dermatol Res, 289:21-27, 1996. Tam S-Y, Tsai M, Yamaguchi M, Yano K, Butterfield JH, Galli SJ: Expression of Functional TrkA Receptor Tyrosine Kinase in the HMC-1 Human Mast Cell Line and in Human Mast Cells. Blood, 90(5):1807-1820, September 1997. Schumacher U, van Damme EJM, Peumans, WJ, Butterfield JH, BS: Lectin Histochemistry of Human Leukaemic Mast Cells (HMC-1) Transplanted into Severe Combined Immunodeficient (scid) Mice. Acta histochem, 100:1-9, 1998. Maeda K, Taniguchi H, Ohno I, Ohtsu H, Yamauchi K, Sakurai E, Tanno Y, Butterfield JH, Watanabe T, Shirato K: Induction of L-Histidine Decarboxylase in a Human Mast Cell Line, HMC-1. Exp Hemat, 26:325- 331, 1998. Butterfield JH: Response of Severe Systemic Mastocytosis to Interferon Alpha. British J Dermat, 138:489-495, 1998. Schulman ES, Glaum MC, Post T, Wang Y, Raible DG, Mohanty J, Butterfield JH, Pelleg A: ATP Modulates Anti-IgE-Induced Release of Histamine from Human Lung Mast Cells. Am J Respir Cell Mol Biol, 20:530-537, 1999. Nicklas RA, Bernstein IL, Li JTC, et al. The diagnosis and management of anaphylaxis. J Allergy and Clin Immunol 101:S465-S528, 1998. Li JTC, CE. Asthma Induced by aspirin and metabisulfite. Current Therapy of Respiratory Disease-3, Cherniack. 137-141, 1989. Khan DA, Li JTC. Allergic bronchopulmonary aspergillosis. IN: Medicine for the Practicing Physician, pp 169-172, 4th Ed., 1996. Hurst JW (ed). Appleton Lange, Norwalk, CT. Li JTC. Mosquito Hypersensitivity. Ann Allergy 58:385, 1987. (Letter) Quereshi S, Li JTC. Syncope in systemic mastocytosis. Ann Allergy 72:70, 1994. Li JTC, Estes LL, Markus PJ, Osmon DR, Gosselin VA, Hanssen AD. Penicillinand cephalosporin allergy in hospitalized patients. Ann Allergy Asthma Immunol, 1999. DL, Yunginger JW, Dunn WF, RT, Hunt LW: Anaphylaxis Induced by the Carboxymethylcellulose Component of Injectable Triamcinolone Acetonide Suspension (Kenalog). ls of Allergy, 74 (2), 163-166, February 1995. Yocum MW. Anaphylaxis. In Hurst JW (editor in chief) Medicine for the Practicing Physician 1995, Appleton and Lange Yocum MW. Systemic mast cell disease. In Hurst JW. (editor in chief) Medicine for the Practicing Physician , 1995, Appleton and Lange. Klein JS, Yocum MW: Emergency room period incidence of community- onset anaphylaxis. J Allergy Clin Immunol 95:637-638, 1995. MW Yocum, JH Butterfield: Aspirin desensitization of a mastocytosis patient. Ann Allergy 74:79, 1995. Van Dellen RG, Gleich GJ: Penicillin skin tests as predictive and diagnostic aids in penicillin allergy. Med Clin N Amer July 1970; 54:997-1007. Van Dellen RG, s GA, Walsh WE, Gleich GJ: Differing patterns of wheal and flare skin reactivity in patients allergic to the penicillins. J Allergy April 1971; 47:230-236. Van Dellen RG, s GA: Acute anaphylactic reactions and aspirin allergy. Postgrad Med May 1979; 49:197-201. Van Dellen RG: Prediction of penicillin hypersensitivity reaction (abstract). p. 44 in: Clinical Reviews, Rochester, MN. Nov 1969; p. 56. Van Dellen RG, Gleich GJ, Walsh WE: Differing patterns of wheal and flare skin reactivity in patients allergic to the penicillins (abstract). J Allergy Feb 1970; 45:121. Solley GO, Gleich GJ, Van Dellen RG: Evaluation of skin tests in patients with penicillin allergy (abstract 170). J Allergy Clin Immunol March 1979; 63:184. Van Dellen RG, Batts KP, PE: Mastocytosis limited to the gastrointestinal tract. Report of a patient with severe diarrhea improved with treatment (abstract). Ann Allergy, Asthma & Immunol 1998; 80:85. Valyasevi MA, Van Dellen RG: Systemic reaction to penicillin skin testing (abstract). Ann Allergy, Asthma, & Immunol 1999; 82:88. Van Dellen RG: Exercise-induced anaphylaxis (clinical brief). Mayo Clin Proc Feb 1981; 56:133. Links for Related Topics Allergy Education Materials American Academy of Allergy, Asthma & Immunology American College of Allergy, Asthma & Immunology Asthma and Allergy Foundation of America LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE USE OF THIS SITE SIGNIFIES YOUR AGREEMENT TO THE TERMS OF USE File other-allergic.htm last modified: Wednesday, 18-Jul-2001 12:33:55 CDT Copyright © 1995-2002 Mayo Foundation for Medical Education and Research. . > > Hello All, > > Can anyone direct me to some certain information without me having to spend hours searching for it? I am in need of this for the media binder that I'm preparing for next week. If you can be of assistance, please write me directly at this addy. You might also post to the group too as it might help others as well. Below is what I need: > > 1. Where to find the Mayo Clinic study on Rhinosinusitis and Mold exposure; > > 2. The Long Article that was posted on either this group or toxic mold survivors group: It was on how long scientists, etc. have known about mold exposures and health concerns. It believe it was posted by a doctor. I can't remember which group... it could be been TMS. (I hope someone remembers this article as it was a great one.) > > 3. Any information regarding the CA Toxic Mold Bill; and any other states that have bills of this nature; > > 4. The Mark Tatum Story by the Associated Press with the picture without his prosthetic face. Mark has mucormycosis. > > 5. The JAMA article pertaining to mycotoxins that came out a while back. Can this be obtained without cost? > > 6. And if there is any way to quickly find a number of articles on SCHOOLS WITH TOXIC MOLD; > > 7. and lastly (I think): Any information pertaining to Toxic Mold and Multiple Chemical Sensitivity. The article by Sheila Bastein was good, but don't know where to obtain a copy from the internet. > > YOUR HELP IS GREATLY APPRECIATED. Also, thanks to all that have been so gracious to send personal stories for the binder that I'm preparing. I will be forever grateful! > > Beverly Weikert > > National Toxic Mold Coalition > > Public Relations Supervisor/Board Member > > www.geocities.com/marbme12/NTMC.html > > Homeowners Against Deficient Dwellings > > Indiana Representative > > www.hadd.com > > Consultant to The Environmental Health Research Group > > www.myhealthrights.com > > > > > > --------------------------------- > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 20, 2002 Report Share Posted April 20, 2002 Beverly, Attached, in PDF format, is the Mayo Clinic Article. ph P. Klein, Sr. Beverly Weikert <weikert004@...> wrote: Hello All, Can anyone direct me to some certain information without me having to spend hours searching for it? I am in need of this for the media binder that I'm preparing for next week. If you can be of assistance, please write me directly at this addy. You might also post to the group too as it might help others as well. Below is what I need: 1. Where to find the Mayo Clinic study on Rhinosinusitis and Mold exposure; 2. The Long Article that was posted on either this group or toxic mold survivors group: It was on how long scientists, etc. have known about mold exposures and health concerns. It believe it was posted by a doctor. I can't remember which group... it could be been TMS. (I hope someone remembers this article as it was a great one.) 3. Any information regarding the CA Toxic Mold Bill; and any other states that have bills of this nature; 4. The Mark Tatum Story by the Associated Press with the picture without his prosthetic face. Mark has mucormycosis. 5. The JAMA article pertaining to mycotoxins that came out a while back. Can this be obtained without cost? 6. And if there is any way to quickly find a number of articles on SCHOOLS WITH TOXIC MOLD; 7. and lastly (I think): Any information pertaining to Toxic Mold and Multiple Chemical Sensitivity. The article by Sheila Bastein was good, but don't know where to obtain a copy from the internet. YOUR HELP IS GREATLY APPRECIATED. Also, thanks to all that have been so gracious to send personal stories for the binder that I'm preparing. I will be forever grateful! Beverly Weikert National Toxic Mold Coalition Public Relations Supervisor/Board Member www.geocities.com/marbme12/NTMC.html Homeowners Against Deficient Dwellings Indiana Representative www.hadd.com Consultant to The Environmental Health Research Group www.myhealthrights.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 23, 2002 Report Share Posted April 23, 2002 I sent Ottilia the Myth of Autism. Kathy -NNY Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.